Annual Drug Patent Expiration for QULIPTA
Qulipta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from a single supplier. There are four patents protecting this drug.
QULIPTA drug price trends.
This drug has eighty-four patent family members in forty-one countries.
The generic ingredient in QULIPTA is atogepant. One registered supplier for this compound. Additional details are available on the atogepant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New Patent for Abbvie Inc QULIPTA drug